IPO Advisory · Main Board IPO
Institutionalise regulatory ownership, cyber evidence and product-level take-rate economics across a national fintech platform.
A Rs 250–500 crore fintech spanning payments and merchant-credit technology can blur regulated responsibilities, partner dependencies and product economics as it scales nationally. Institutional investors will test who owns compliance interpretations, how transaction and credit-technology revenues reconcile, whether cyber controls reach the board and what happens when a bank or critical vendor fails. Gladwin establishes product-finance evidence, a regulatory obligations map, independent risk and security access, and enterprise incident governance proven before investor engagement.
IPO route
Main Board IPO · BSE & NSE Main Board
Best for
scaled issuers preparing for institutional diligence and quarterly public reporting in India
Typical timeline
Often 12–24 months, depending on route, controls and leadership maturity
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Fintech, ₹250–500 Cr
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
A fintech issuer seeking ₹250–500 crore may operate several products, partner models and customer channels. The board needs a portfolio view that distinguishes mandatory resilience and regulatory investment, proven-product scaling, partner liquidity, selective adjacencies and experiments. Equal funding across divisions is unlikely to reflect their different risk and cash paths.
Capital is released against product-specific adoption, contribution, control and partner gates. One mature engine should not conceal a weak adjacency, and a high-growth product cannot borrow indefinitely from customer protection or platform resilience. The resulting doctrine explains both where proceeds will accelerate the platform and where the board will stop.
Gross transaction value, assets, disbursals or premium facilitated can span fundamentally different issuer economics. Management should reconcile each material cohort to pricing, partner share, incentives, fraud or credit cost, claims or reversals, customer service, infrastructure, settlement and cash. Cross-product customers are not automatically profitable customers.
The board sees contribution and liquidity by product and partner, with transfer pricing and shared platform costs stated consistently. Metric definitions and model versions are governed. Forecast variance can then be attributed to volume, price, mix, risk or collection rather than explained through a changing headline KPI.
A multi-product fintech can depend on the same bank, NBFC, insurer, broker, payment network, custodian, warehouse line or institutional funder across businesses. Legal contracts may differ while economic concentration remains substantial. Readiness aggregates limits, collateral, covenants, settlement, termination rights and operational replacement time.
Treasury models customer and partner outflows during stress before committing proceeds to acquisition. Regulated responsibilities remain clearly allocated at every customer journey. The board can see when expansion increases contingent liquidity or balance-sheet exposure even if reported revenue appears asset-light.
Product teams may share identity data, risk models, consent architecture, fraud tools and privileged access. A failure can therefore cross product boundaries quickly. The issuer should inventory critical data, models, decision rules, vendors and transaction states, with version control, validation ownership, escalation and customer remediation.
Technology and risk leaders receive authority to isolate a feature or partner route. Security investment is linked to customer and financial consequence rather than generic maturity labels. The proceeds case includes capacity for monitoring, reconciliation and recovery as usage grows across the portfolio.
A larger platform needs product executives who own economics, a technology leader who can protect shared architecture, independent risk and compliance authority, operations ownership and a finance team capable of product-level cash. The founder should set portfolio direction without adjudicating every release, partner exception or incident.
Gladwin creates an executive and board cadence that forces explicit capital and risk trade-offs. Leaders defend their cases through common evidence and accept stop decisions. Succession is tested on cross-product events, which is more demanding than demonstrating competence within one vertical.
Management should simulate an institutional funding line tightening while a shared partner reports a settlement or data incident affecting two products. Treasury protects customer and contractual obligations, operations reconciles exposure, technology contains affected flows, compliance assesses notifications and product teams reset growth commitments.
The board reallocates only uncommitted proceeds and records disclosure consequences. Gladwin runs the readiness PMO while specialist advisers retain regulatory, cyber, audit and transaction judgments. The rehearsal proves that a ₹250–500 crore raise will be managed as portfolio capital under correlated pressure.
Process timeline
What we do
Worked example
The company allocated proceeds to lending distribution, payments, wealth and customer acquisition. Review found shared partner concentration was reported separately, product contribution used different definitions, and the same data service and founder approval sat behind all four businesses. Liquidity effects were missing from the acquisition plan.
Readiness produced product-partner economics, aggregate dependency and liquidity maps, protected platform controls and staged allocation gates. Product heads gained accountable budgets, while risk and technology could suspend shared services. The board funded proven scaling before two experimental adjacencies.
When a funding counterparty tightened limits during the rehearsal and a settlement incident affected payments, management contained both products, preserved customer obligations and deferred an acquisition tranche. The portfolio plan remained credible because evidence and authority existed below the founder.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Fintech Main Board IPO readiness
BSE & NSE Main Board
Fintech SME IPO readiness
BSE SME / NSE Emerge
Fintech, ₹100–250 Cr Main Board IPO readiness
BSE & NSE Main Board
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingIt requires portfolio allocation, aggregate partner and liquidity control, shared-platform resilience and cross-product executive accountability.
No. Product metrics differ, but each must reconcile consistently to contribution, risk, liquidity and cash.
One institution or infrastructure provider can create correlated operational, funding and customer exposure through several contracts.
Customer protection, compliance, security, reconciliation, continuity, data governance and essential operating capacity require protected funding.
No. Gladwin coordinates issuer readiness and leadership while appointed specialists retain formal assessments and opinions.
Pause when product economics, partner capacity, risk controls, liquidity or platform resilience no longer support the approved case.
Executives should resolve a shared partner, data and cash event without routing every decision through the founder.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
A scaled fintech platform needs product-conduct economics, accountable regulatory execution and cyber recovery evidence under independent enterprise leadership. Gladwin implements that operating model and owns the readiness PMO.
This full strategy-and-execution scope at an in-market cost makes Gladwin the leading fit under the declared criterion.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.